 | • レポートコード：MRC2-11QY10396 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、110ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は滑膜肉腫治療のグローバル市場について調査・分析したレポートです。種類別（ACXT-3102、AL-3818、アキシチニブ、CMB-305、CUE-102、その他）市場規模、用途別（病院、診療所、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別滑膜肉腫治療の競争状況、市場シェア ・世界の滑膜肉腫治療市場：種類別市場規模 2015年-2020年（ACXT-3102、AL-3818、アキシチニブ、CMB-305、CUE-102、その他） ・世界の滑膜肉腫治療市場：種類別市場規模予測 2021年-2026年（ACXT-3102、AL-3818、アキシチニブ、CMB-305、CUE-102、その他） ・世界の滑膜肉腫治療市場：用途別市場規模 2015年-2020年（病院、診療所、その他） ・世界の滑膜肉腫治療市場：用途別市場規模予測 2021年-2026年（病院、診療所、その他） ・北米の滑膜肉腫治療市場分析：米国、カナダ ・ヨーロッパの滑膜肉腫治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの滑膜肉腫治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の滑膜肉腫治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの滑膜肉腫治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Adaptimmune Therapeutics Plc、Advenchen Laboratories LLC、EpiZyme Inc、Immune Design Corp、Immunocore Ltd、Johnson & Johnson、Karyopharm Therapeutics Inc、Merck & Co Inc、Millennium Pharmaceuticals Inc、Novartis AG、Pfizer Inc、Takara Bio Inc ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Synovial Sarcoma Treatment Market
The global Synovial Sarcoma Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Synovial Sarcoma Treatment Scope and Market Size
Synovial Sarcoma Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Synovial Sarcoma Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Synovial Sarcoma Treatment market is segmented into
ACXT-3102
AL-3818
Axitinib
CMB-305
CUE-102
Others
Segment by Application, the Synovial Sarcoma Treatment market is segmented into
Hospital
Clinic
Others
Regional and Country-level Analysis
The Synovial Sarcoma Treatment market is analysed and market size information is provided by regions (countries).
The key regions covered in the Synovial Sarcoma Treatment market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Synovial Sarcoma Treatment Market Share Analysis
Synovial Sarcoma Treatment market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Synovial Sarcoma Treatment business, the date to enter into the Synovial Sarcoma Treatment market, Synovial Sarcoma Treatment product introduction, recent developments, etc.
The major vendors covered:
Adaptimmune Therapeutics Plc
Advenchen Laboratories LLC
EpiZyme Inc
Immune Design Corp
Immunocore Ltd
Johnson & Johnson
Karyopharm Therapeutics Inc
Merck & Co Inc
Millennium Pharmaceuticals Inc
Novartis AG
Pfizer Inc
Takara Bio Inc
1 Study Coverage
1.1 Synovial Sarcoma Treatment Product Introduction
1.2 Market Segments
1.3 Key Synovial Sarcoma Treatment Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Synovial Sarcoma Treatment Market Size Growth Rate by Type
1.4.2 ACXT-3102
1.4.3 AL-3818
1.4.4 Axitinib
1.4.5 CMB-305
1.4.6 CUE-102
1.4.7 Others
1.5 Market by Application
1.5.1 Global Synovial Sarcoma Treatment Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Synovial Sarcoma Treatment Market Size, Estimates and Forecasts
2.1.1 Global Synovial Sarcoma Treatment Revenue 2015-2026
2.1.2 Global Synovial Sarcoma Treatment Sales 2015-2026
2.2 Global Synovial Sarcoma Treatment, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Synovial Sarcoma Treatment Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Synovial Sarcoma Treatment Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Synovial Sarcoma Treatment Competitor Landscape by Players
3.1 Synovial Sarcoma Treatment Sales by Manufacturers
3.1.1 Synovial Sarcoma Treatment Sales by Manufacturers (2015-2020)
3.1.2 Synovial Sarcoma Treatment Sales Market Share by Manufacturers (2015-2020)
3.2 Synovial Sarcoma Treatment Revenue by Manufacturers
3.2.1 Synovial Sarcoma Treatment Revenue by Manufacturers (2015-2020)
3.2.2 Synovial Sarcoma Treatment Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Synovial Sarcoma Treatment Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Synovial Sarcoma Treatment Revenue in 2019
3.2.5 Global Synovial Sarcoma Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Synovial Sarcoma Treatment Price by Manufacturers
3.4 Synovial Sarcoma Treatment Manufacturing Base Distribution, Product Types
3.4.1 Synovial Sarcoma Treatment Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Synovial Sarcoma Treatment Product Type
3.4.3 Date of International Manufacturers Enter into Synovial Sarcoma Treatment Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Synovial Sarcoma Treatment Market Size by Type (2015-2020)
4.1.1 Global Synovial Sarcoma Treatment Sales by Type (2015-2020)
4.1.2 Global Synovial Sarcoma Treatment Revenue by Type (2015-2020)
4.1.3 Synovial Sarcoma Treatment Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Synovial Sarcoma Treatment Market Size Forecast by Type (2021-2026)
4.2.1 Global Synovial Sarcoma Treatment Sales Forecast by Type (2021-2026)
4.2.2 Global Synovial Sarcoma Treatment Revenue Forecast by Type (2021-2026)
4.2.3 Synovial Sarcoma Treatment Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Synovial Sarcoma Treatment Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Synovial Sarcoma Treatment Market Size by Application (2015-2020)
5.1.1 Global Synovial Sarcoma Treatment Sales by Application (2015-2020)
5.1.2 Global Synovial Sarcoma Treatment Revenue by Application (2015-2020)
5.1.3 Synovial Sarcoma Treatment Price by Application (2015-2020)
5.2 Synovial Sarcoma Treatment Market Size Forecast by Application (2021-2026)
5.2.1 Global Synovial Sarcoma Treatment Sales Forecast by Application (2021-2026)
5.2.2 Global Synovial Sarcoma Treatment Revenue Forecast by Application (2021-2026)
5.2.3 Global Synovial Sarcoma Treatment Price Forecast by Application (2021-2026)
6 North America
6.1 North America Synovial Sarcoma Treatment by Country
6.1.1 North America Synovial Sarcoma Treatment Sales by Country
6.1.2 North America Synovial Sarcoma Treatment Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Synovial Sarcoma Treatment Market Facts & Figures by Type
6.3 North America Synovial Sarcoma Treatment Market Facts & Figures by Application
7 Europe
7.1 Europe Synovial Sarcoma Treatment by Country
7.1.1 Europe Synovial Sarcoma Treatment Sales by Country
7.1.2 Europe Synovial Sarcoma Treatment Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Synovial Sarcoma Treatment Market Facts & Figures by Type
7.3 Europe Synovial Sarcoma Treatment Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Synovial Sarcoma Treatment by Region
8.1.1 Asia Pacific Synovial Sarcoma Treatment Sales by Region
8.1.2 Asia Pacific Synovial Sarcoma Treatment Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Synovial Sarcoma Treatment Market Facts & Figures by Type
8.3 Asia Pacific Synovial Sarcoma Treatment Market Facts & Figures by Application
9 Latin America
9.1 Latin America Synovial Sarcoma Treatment by Country
9.1.1 Latin America Synovial Sarcoma Treatment Sales by Country
9.1.2 Latin America Synovial Sarcoma Treatment Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Synovial Sarcoma Treatment Market Facts & Figures by Type
9.3 Central & South America Synovial Sarcoma Treatment Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Synovial Sarcoma Treatment by Country
10.1.1 Middle East and Africa Synovial Sarcoma Treatment Sales by Country
10.1.2 Middle East and Africa Synovial Sarcoma Treatment Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Synovial Sarcoma Treatment Market Facts & Figures by Type
10.3 Middle East and Africa Synovial Sarcoma Treatment Market Facts & Figures by Application
11 Company Profiles
11.1 Adaptimmune Therapeutics Plc
11.1.1 Adaptimmune Therapeutics Plc Corporation Information
11.1.2 Adaptimmune Therapeutics Plc Description and Business Overview
11.1.3 Adaptimmune Therapeutics Plc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Adaptimmune Therapeutics Plc Synovial Sarcoma Treatment Products Offered
11.1.5 Adaptimmune Therapeutics Plc Related Developments
11.2 Advenchen Laboratories LLC
11.2.1 Advenchen Laboratories LLC Corporation Information
11.2.2 Advenchen Laboratories LLC Description and Business Overview
11.2.3 Advenchen Laboratories LLC Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Advenchen Laboratories LLC Synovial Sarcoma Treatment Products Offered
11.2.5 Advenchen Laboratories LLC Related Developments
11.3 EpiZyme Inc
11.3.1 EpiZyme Inc Corporation Information
11.3.2 EpiZyme Inc Description and Business Overview
11.3.3 EpiZyme Inc Sales, Revenue and Gross Margin (2015-2020)
11.3.4 EpiZyme Inc Synovial Sarcoma Treatment Products Offered
11.3.5 EpiZyme Inc Related Developments
11.4 Immune Design Corp
11.4.1 Immune Design Corp Corporation Information
11.4.2 Immune Design Corp Description and Business Overview
11.4.3 Immune Design Corp Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Immune Design Corp Synovial Sarcoma Treatment Products Offered
11.4.5 Immune Design Corp Related Developments
11.5 Immunocore Ltd
11.5.1 Immunocore Ltd Corporation Information
11.5.2 Immunocore Ltd Description and Business Overview
11.5.3 Immunocore Ltd Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Immunocore Ltd Synovial Sarcoma Treatment Products Offered
11.5.5 Immunocore Ltd Related Developments
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Corporation Information
11.6.2 Johnson & Johnson Description and Business Overview
11.6.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Johnson & Johnson Synovial Sarcoma Treatment Products Offered
11.6.5 Johnson & Johnson Related Developments
11.7 Karyopharm Therapeutics Inc
11.7.1 Karyopharm Therapeutics Inc Corporation Information
11.7.2 Karyopharm Therapeutics Inc Description and Business Overview
11.7.3 Karyopharm Therapeutics Inc Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Karyopharm Therapeutics Inc Synovial Sarcoma Treatment Products Offered
11.7.5 Karyopharm Therapeutics Inc Related Developments
11.8 Merck & Co Inc
11.8.1 Merck & Co Inc Corporation Information
11.8.2 Merck & Co Inc Description and Business Overview
11.8.3 Merck & Co Inc Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Merck & Co Inc Synovial Sarcoma Treatment Products Offered
11.8.5 Merck & Co Inc Related Developments
11.9 Millennium Pharmaceuticals Inc
11.9.1 Millennium Pharmaceuticals Inc Corporation Information
11.9.2 Millennium Pharmaceuticals Inc Description and Business Overview
11.9.3 Millennium Pharmaceuticals Inc Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Millennium Pharmaceuticals Inc Synovial Sarcoma Treatment Products Offered
11.9.5 Millennium Pharmaceuticals Inc Related Developments
11.10 Novartis AG
11.10.1 Novartis AG Corporation Information
11.10.2 Novartis AG Description and Business Overview
11.10.3 Novartis AG Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Novartis AG Synovial Sarcoma Treatment Products Offered
11.10.5 Novartis AG Related Developments
11.1 Adaptimmune Therapeutics Plc
11.1.1 Adaptimmune Therapeutics Plc Corporation Information
11.1.2 Adaptimmune Therapeutics Plc Description and Business Overview
11.1.3 Adaptimmune Therapeutics Plc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Adaptimmune Therapeutics Plc Synovial Sarcoma Treatment Products Offered
11.1.5 Adaptimmune Therapeutics Plc Related Developments
11.12 Takara Bio Inc
11.12.1 Takara Bio Inc Corporation Information
11.12.2 Takara Bio Inc Description and Business Overview
11.12.3 Takara Bio Inc Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Takara Bio Inc Products Offered
11.12.5 Takara Bio Inc Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Synovial Sarcoma Treatment Market Estimates and Projections by Region
12.1.1 Global Synovial Sarcoma Treatment Sales Forecast by Regions 2021-2026
12.1.2 Global Synovial Sarcoma Treatment Revenue Forecast by Regions 2021-2026
12.2 North America Synovial Sarcoma Treatment Market Size Forecast (2021-2026)
12.2.1 North America: Synovial Sarcoma Treatment Sales Forecast (2021-2026)
12.2.2 North America: Synovial Sarcoma Treatment Revenue Forecast (2021-2026)
12.2.3 North America: Synovial Sarcoma Treatment Market Size Forecast by Country (2021-2026)
12.3 Europe Synovial Sarcoma Treatment Market Size Forecast (2021-2026)
12.3.1 Europe: Synovial Sarcoma Treatment Sales Forecast (2021-2026)
12.3.2 Europe: Synovial Sarcoma Treatment Revenue Forecast (2021-2026)
12.3.3 Europe: Synovial Sarcoma Treatment Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Synovial Sarcoma Treatment Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Synovial Sarcoma Treatment Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Synovial Sarcoma Treatment Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Synovial Sarcoma Treatment Market Size Forecast by Region (2021-2026)
12.5 Latin America Synovial Sarcoma Treatment Market Size Forecast (2021-2026)
12.5.1 Latin America: Synovial Sarcoma Treatment Sales Forecast (2021-2026)
12.5.2 Latin America: Synovial Sarcoma Treatment Revenue Forecast (2021-2026)
12.5.3 Latin America: Synovial Sarcoma Treatment Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Synovial Sarcoma Treatment Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Synovial Sarcoma Treatment Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Synovial Sarcoma Treatment Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Synovial Sarcoma Treatment Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Synovial Sarcoma Treatment Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Synovial Sarcoma Treatment Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Synovial Sarcoma Treatment Market Segments
Table 2. Ranking of Global Top Synovial Sarcoma Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Synovial Sarcoma Treatment Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of ACXT-3102
Table 5. Major Manufacturers of AL-3818
Table 6. Major Manufacturers of Axitinib
Table 7. Major Manufacturers of CMB-305
Table 8. Major Manufacturers of CUE-102
Table 9. Major Manufacturers of Others
Table 10. Global Synovial Sarcoma Treatment Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 11. Global Synovial Sarcoma Treatment Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 12. Global Synovial Sarcoma Treatment Sales by Regions 2015-2020 (K Pcs)
Table 13. Global Synovial Sarcoma Treatment Sales Market Share by Regions (2015-2020)
Table 14. Global Synovial Sarcoma Treatment Revenue by Regions 2015-2020 (US$ Million)
Table 15. Global Synovial Sarcoma Treatment Sales by Manufacturers (2015-2020) (K Pcs)
Table 16. Global Synovial Sarcoma Treatment Sales Share by Manufacturers (2015-2020)
Table 17. Global Synovial Sarcoma Treatment Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 18. Global Synovial Sarcoma Treatment by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Synovial Sarcoma Treatment as of 2019)
Table 19. Synovial Sarcoma Treatment Revenue by Manufacturers (2015-2020) (US$ Million)
Table 20. Synovial Sarcoma Treatment Revenue Share by Manufacturers (2015-2020)
Table 21. Key Manufacturers Synovial Sarcoma Treatment Price (2015-2020) (USD/Pcs)
Table 22. Synovial Sarcoma Treatment Manufacturers Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Synovial Sarcoma Treatment Product Type
Table 24. Date of International Manufacturers Enter into Synovial Sarcoma Treatment Market
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Global Synovial Sarcoma Treatment Sales by Type (2015-2020) (K Pcs)
Table 27. Global Synovial Sarcoma Treatment Sales Share by Type (2015-2020)
Table 28. Global Synovial Sarcoma Treatment Revenue by Type (2015-2020) (US$ Million)
Table 29. Global Synovial Sarcoma Treatment Revenue Share by Type (2015-2020)
Table 30. Synovial Sarcoma Treatment Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 31. Global Synovial Sarcoma Treatment Sales by Application (2015-2020) (K Pcs)
Table 32. Global Synovial Sarcoma Treatment Sales Share by Application (2015-2020)
Table 33. North America Synovial Sarcoma Treatment Sales by Country (2015-2020) (K Pcs)
Table 34. North America Synovial Sarcoma Treatment Sales Market Share by Country (2015-2020)
Table 35. North America Synovial Sarcoma Treatment Revenue by Country (2015-2020) (US$ Million)
Table 36. North America Synovial Sarcoma Treatment Revenue Market Share by Country (2015-2020)
Table 37. North America Synovial Sarcoma Treatment Sales by Type (2015-2020) (K Pcs)
Table 38. North America Synovial Sarcoma Treatment Sales Market Share by Type (2015-2020)
Table 39. North America Synovial Sarcoma Treatment Sales by Application (2015-2020) (K Pcs)
Table 40. North America Synovial Sarcoma Treatment Sales Market Share by Application (2015-2020)
Table 41. Europe Synovial Sarcoma Treatment Sales by Country (2015-2020) (K Pcs)
Table 42. Europe Synovial Sarcoma Treatment Sales Market Share by Country (2015-2020)
Table 43. Europe Synovial Sarcoma Treatment Revenue by Country (2015-2020) (US$ Million)
Table 44. Europe Synovial Sarcoma Treatment Revenue Market Share by Country (2015-2020)
Table 45. Europe Synovial Sarcoma Treatment Sales by Type (2015-2020) (K Pcs)
Table 46. Europe Synovial Sarcoma Treatment Sales Market Share by Type (2015-2020)
Table 47. Europe Synovial Sarcoma Treatment Sales by Application (2015-2020) (K Pcs)
Table 48. Europe Synovial Sarcoma Treatment Sales Market Share by Application (2015-2020)
Table 49. Asia Pacific Synovial Sarcoma Treatment Sales by Region (2015-2020) (K Pcs)
Table 50. Asia Pacific Synovial Sarcoma Treatment Sales Market Share by Region (2015-2020)
Table 51. Asia Pacific Synovial Sarcoma Treatment Revenue by Region (2015-2020) (US$ Million)
Table 52. Asia Pacific Synovial Sarcoma Treatment Revenue Market Share by Region (2015-2020)
Table 53. Asia Pacific Synovial Sarcoma Treatment Sales by Type (2015-2020) (K Pcs)
Table 54. Asia Pacific Synovial Sarcoma Treatment Sales Market Share by Type (2015-2020)
Table 55. Asia Pacific Synovial Sarcoma Treatment Sales by Application (2015-2020) (K Pcs)
Table 56. Asia Pacific Synovial Sarcoma Treatment Sales Market Share by Application (2015-2020)
Table 57. Latin America Synovial Sarcoma Treatment Sales by Country (2015-2020) (K Pcs)
Table 58. Latin America Synovial Sarcoma Treatment Sales Market Share by Country (2015-2020)
Table 59. Latin Americaa Synovial Sarcoma Treatment Revenue by Country (2015-2020) (US$ Million)
Table 60. Latin America Synovial Sarcoma Treatment Revenue Market Share by Country (2015-2020)
Table 61. Latin America Synovial Sarcoma Treatment Sales by Type (2015-2020) (K Pcs)
Table 62. Latin America Synovial Sarcoma Treatment Sales Market Share by Type (2015-2020)
Table 63. Latin America Synovial Sarcoma Treatment Sales by Application (2015-2020) (K Pcs)
Table 64. Latin America Synovial Sarcoma Treatment Sales Market Share by Application (2015-2020)
Table 65. Middle East and Africa Synovial Sarcoma Treatment Sales by Country (2015-2020) (K Pcs)
Table 66. Middle East and Africa Synovial Sarcoma Treatment Sales Market Share by Country (2015-2020)
Table 67. Middle East and Africa Synovial Sarcoma Treatment Revenue by Country (2015-2020) (US$ Million)
Table 68. Middle East and Africa Synovial Sarcoma Treatment Revenue Market Share by Country (2015-2020)
Table 69. Middle East and Africa Synovial Sarcoma Treatment Sales by Type (2015-2020) (K Pcs)
Table 70. Middle East and Africa Synovial Sarcoma Treatment Sales Market Share by Type (2015-2020)
Table 71. Middle East and Africa Synovial Sarcoma Treatment Sales by Application (2015-2020) (K Pcs)
Table 72. Middle East and Africa Synovial Sarcoma Treatment Sales Market Share by Application (2015-2020)
Table 73. Adaptimmune Therapeutics Plc Corporation Information
Table 74. Adaptimmune Therapeutics Plc Description and Major Businesses
Table 75. Adaptimmune Therapeutics Plc Synovial Sarcoma Treatment Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 76. Adaptimmune Therapeutics Plc Product
Table 77. Adaptimmune Therapeutics Plc Recent Development
Table 78. Advenchen Laboratories LLC Corporation Information
Table 79. Advenchen Laboratories LLC Description and Major Businesses
Table 80. Advenchen Laboratories LLC Synovial Sarcoma Treatment Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 81. Advenchen Laboratories LLC Product
Table 82. Advenchen Laboratories LLC Recent Development
Table 83. EpiZyme Inc Corporation Information
Table 84. EpiZyme Inc Description and Major Businesses
Table 85. EpiZyme Inc Synovial Sarcoma Treatment Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 86. EpiZyme Inc Product
Table 87. EpiZyme Inc Recent Development
Table 88. Immune Design Corp Corporation Information
Table 89. Immune Design Corp Description and Major Businesses
Table 90. Immune Design Corp Synovial Sarcoma Treatment Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 91. Immune Design Corp Product
Table 92. Immune Design Corp Recent Development
Table 93. Immunocore Ltd Corporation Information
Table 94. Immunocore Ltd Description and Major Businesses
Table 95. Immunocore Ltd Synovial Sarcoma Treatment Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 96. Immunocore Ltd Product
Table 97. Immunocore Ltd Recent Development
Table 98. Johnson & Johnson Corporation Information
Table 99. Johnson & Johnson Description and Major Businesses
Table 100. Johnson & Johnson Synovial Sarcoma Treatment Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 101. Johnson & Johnson Product
Table 102. Johnson & Johnson Recent Development
Table 103. Karyopharm Therapeutics Inc Corporation Information
Table 104. Karyopharm Therapeutics Inc Description and Major Businesses
Table 105. Karyopharm Therapeutics Inc Synovial Sarcoma Treatment Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 106. Karyopharm Therapeutics Inc Product
Table 107. Karyopharm Therapeutics Inc Recent Development
Table 108. Merck & Co Inc Corporation Information
Table 109. Merck & Co Inc Description and Major Businesses
Table 110. Merck & Co Inc Synovial Sarcoma Treatment Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 111. Merck & Co Inc Product
Table 112. Merck & Co Inc Recent Development
Table 113. Millennium Pharmaceuticals Inc Corporation Information
Table 114. Millennium Pharmaceuticals Inc Description and Major Businesses
Table 115. Millennium Pharmaceuticals Inc Synovial Sarcoma Treatment Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 116. Millennium Pharmaceuticals Inc Product
Table 117. Millennium Pharmaceuticals Inc Recent Development
Table 118. Novartis AG Corporation Information
Table 119. Novartis AG Description and Major Businesses
Table 120. Novartis AG Synovial Sarcoma Treatment Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 121. Novartis AG Product
Table 122. Novartis AG Recent Development
Table 123. Pfizer Inc Corporation Information
Table 124. Pfizer Inc Description and Major Businesses
Table 125. Pfizer Inc Synovial Sarcoma Treatment Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 126. Pfizer Inc Product
Table 127. Pfizer Inc Recent Development
Table 128. Takara Bio Inc Corporation Information
Table 129. Takara Bio Inc Description and Major Businesses
Table 130. Takara Bio Inc Synovial Sarcoma Treatment Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 131. Takara Bio Inc Product
Table 132. Takara Bio Inc Recent Development
Table 133. Global Synovial Sarcoma Treatment Sales Forecast by Regions (2021-2026) (K Pcs)
Table 134. Global Synovial Sarcoma Treatment Sales Market Share Forecast by Regions (2021-2026)
Table 135. Global Synovial Sarcoma Treatment Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 136. Global Synovial Sarcoma Treatment Revenue Market Share Forecast by Regions (2021-2026)
Table 137. North America: Synovial Sarcoma Treatment Sales Forecast by Country (2021-2026) (K Pcs)
Table 138. North America: Synovial Sarcoma Treatment Revenue Forecast by Country (2021-2026) (US$ Million)
Table 139. Europe: Synovial Sarcoma Treatment Sales Forecast by Country (2021-2026) (K Pcs)
Table 140. Europe: Synovial Sarcoma Treatment Revenue Forecast by Country (2021-2026) (US$ Million)
Table 141. Asia Pacific: Synovial Sarcoma Treatment Sales Forecast by Region (2021-2026) (K Pcs)
Table 142. Asia Pacific: Synovial Sarcoma Treatment Revenue Forecast by Region (2021-2026) (US$ Million)
Table 143. Latin America: Synovial Sarcoma Treatment Sales Forecast by Country (2021-2026) (K Pcs)
Table 144. Latin America: Synovial Sarcoma Treatment Revenue Forecast by Country (2021-2026) (US$ Million)
Table 145. Middle East and Africa: Synovial Sarcoma Treatment Sales Forecast by Country (2021-2026) (K Pcs)
Table 146. Middle East and Africa: Synovial Sarcoma Treatment Revenue Forecast by Country (2021-2026) (US$ Million)
Table 147. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 148. Key Challenges
Table 149. Market Risks
Table 150. Main Points Interviewed from Key Synovial Sarcoma Treatment Players
Table 151. Synovial Sarcoma Treatment Customers List
Table 152. Synovial Sarcoma Treatment Distributors List
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Synovial Sarcoma Treatment Product Picture
Figure 2. Global Synovial Sarcoma Treatment Sales Market Share by Type in 2020 & 2026
Figure 3. ACXT-3102 Product Picture
Figure 4. AL-3818 Product Picture
Figure 5. Axitinib Product Picture
Figure 6. CMB-305 Product Picture
Figure 7. CUE-102 Product Picture
Figure 8. Others Product Picture
Figure 9. Global Synovial Sarcoma Treatment Sales Market Share by Application in 2020 & 2026
Figure 10. Hospital
Figure 11. Clinic
Figure 12. Others
Figure 13. Synovial Sarcoma Treatment Report Years Considered
Figure 14. Global Synovial Sarcoma Treatment Market Size 2015-2026 (US$ Million)
Figure 15. Global Synovial Sarcoma Treatment Sales 2015-2026 (K Pcs)
Figure 16. Global Synovial Sarcoma Treatment Market Size Market Share by Region: 2020 Versus 2026
Figure 17. Global Synovial Sarcoma Treatment Sales Market Share by Region (2015-2020)
Figure 18. Global Synovial Sarcoma Treatment Sales Market Share by Region in 2019
Figure 19. Global Synovial Sarcoma Treatment Revenue Market Share by Region (2015-2020)
Figure 20. Global Synovial Sarcoma Treatment Revenue Market Share by Region in 2019
Figure 21. Global Synovial Sarcoma Treatment Sales Share by Manufacturer in 2019
Figure 22. The Top 10 and 5 Players Market Share by Synovial Sarcoma Treatment Revenue in 2019
Figure 23. Synovial Sarcoma Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 24. Global Synovial Sarcoma Treatment Sales Market Share by Type (2015-2020)
Figure 25. Global Synovial Sarcoma Treatment Sales Market Share by Type in 2019
Figure 26. Global Synovial Sarcoma Treatment Revenue Market Share by Type (2015-2020)
Figure 27. Global Synovial Sarcoma Treatment Revenue Market Share by Type in 2019
Figure 28. Global Synovial Sarcoma Treatment Market Share by Price Range (2015-2020)
Figure 29. Global Synovial Sarcoma Treatment Sales Market Share by Application (2015-2020)
Figure 30. Global Synovial Sarcoma Treatment Sales Market Share by Application in 2019
Figure 31. Global Synovial Sarcoma Treatment Revenue Market Share by Application (2015-2020)
Figure 32. Global Synovial Sarcoma Treatment Revenue Market Share by Application in 2019
Figure 33. North America Synovial Sarcoma Treatment Sales Growth Rate 2015-2020 (K Pcs)
Figure 34. North America Synovial Sarcoma Treatment Revenue Growth Rate 2015-2020 (US$ Million)
Figure 35. North America Synovial Sarcoma Treatment Sales Market Share by Country in 2019
Figure 36. North America Synovial Sarcoma Treatment Revenue Market Share by Country in 2019
Figure 37. U.S. Synovial Sarcoma Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 38. U.S. Synovial Sarcoma Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. Canada Synovial Sarcoma Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 40. Canada Synovial Sarcoma Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. North America Synovial Sarcoma Treatment Market Share by Type in 2019
Figure 42. North America Synovial Sarcoma Treatment Market Share by Application in 2019
Figure 43. Europe Synovial Sarcoma Treatment Sales Growth Rate 2015-2020 (K Pcs)
Figure 44. Europe Synovial Sarcoma Treatment Revenue Growth Rate 2015-2020 (US$ Million)
Figure 45. Europe Synovial Sarcoma Treatment Sales Market Share by Country in 2019
Figure 46. Europe Synovial Sarcoma Treatment Revenue Market Share by Country in 2019
Figure 47. Germany Synovial Sarcoma Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 48. Germany Synovial Sarcoma Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. France Synovial Sarcoma Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 50. France Synovial Sarcoma Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. U.K. Synovial Sarcoma Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 52. U.K. Synovial Sarcoma Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Italy Synovial Sarcoma Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 54. Italy Synovial Sarcoma Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Russia Synovial Sarcoma Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 56. Russia Synovial Sarcoma Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Europe Synovial Sarcoma Treatment Market Share by Type in 2019
Figure 58. Europe Synovial Sarcoma Treatment Market Share by Application in 2019
Figure 59. Asia Pacific Synovial Sarcoma Treatment Sales Growth Rate 2015-2020 (K Pcs)
Figure 60. Asia Pacific Synovial Sarcoma Treatment Revenue Growth Rate 2015-2020 (US$ Million)
Figure 61. Asia Pacific Synovial Sarcoma Treatment Sales Market Share by Region in 2019
Figure 62. Asia Pacific Synovial Sarcoma Treatment Revenue Market Share by Region in 2019
Figure 63. China Synovial Sarcoma Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 64. China Synovial Sarcoma Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Japan Synovial Sarcoma Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 66. Japan Synovial Sarcoma Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. South Korea Synovial Sarcoma Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 68. South Korea Synovial Sarcoma Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. India Synovial Sarcoma Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 70. India Synovial Sarcoma Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Australia Synovial Sarcoma Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 72. Australia Synovial Sarcoma Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Taiwan Synovial Sarcoma Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 74. Taiwan Synovial Sarcoma Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Indonesia Synovial Sarcoma Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 76. Indonesia Synovial Sarcoma Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Thailand Synovial Sarcoma Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 78. Thailand Synovial Sarcoma Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Malaysia Synovial Sarcoma Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 80. Malaysia Synovial Sarcoma Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Philippines Synovial Sarcoma Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 82. Philippines Synovial Sarcoma Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Vietnam Synovial Sarcoma Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 84. Vietnam Synovial Sarcoma Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Asia Pacific Synovial Sarcoma Treatment Market Share by Type in 2019
Figure 86. Asia Pacific Synovial Sarcoma Treatment Market Share by Application in 2019
Figure 87. Latin America Synovial Sarcoma Treatment Sales Growth Rate 2015-2020 (K Pcs)
Figure 88. Latin America Synovial Sarcoma Treatment Revenue Growth Rate 2015-2020 (US$ Million)
Figure 89. Latin America Synovial Sarcoma Treatment Sales Market Share by Country in 2019
Figure 90. Latin America Synovial Sarcoma Treatment Revenue Market Share by Country in 2019
Figure 91. Mexico Synovial Sarcoma Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 92. Mexico Synovial Sarcoma Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Brazil Synovial Sarcoma Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 94. Brazil Synovial Sarcoma Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Argentina Synovial Sarcoma Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 96. Argentina Synovial Sarcoma Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 97. Latin America Synovial Sarcoma Treatment Market Share by Type in 2019
Figure 98. Latin America Synovial Sarcoma Treatment Market Share by Application in 2019
Figure 99. Middle East and Africa Synovial Sarcoma Treatment Sales Growth Rate 2015-2020 (K Pcs)
Figure 100. Middle East and Africa Synovial Sarcoma Treatment Revenue Growth Rate 2015-2020 (US$ Million)
Figure 101. Middle East and Africa Synovial Sarcoma Treatment Sales Market Share by Country in 2019
Figure 102. Middle East and Africa Synovial Sarcoma Treatment Revenue Market Share by Country in 2019
Figure 103. Turkey Synovial Sarcoma Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 104. Turkey Synovial Sarcoma Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Saudi Arabia Synovial Sarcoma Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 106. Saudi Arabia Synovial Sarcoma Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. U.A.E Synovial Sarcoma Treatment Sales Growth Rate (2015-2020) (K Pcs)
Figure 108. U.A.E Synovial Sarcoma Treatment Revenue Growth Rate (2015-2020) (US$ Million)
Figure 109. Middle East and Africa Synovial Sarcoma Treatment Market Share by Type in 2019
Figure 110. Middle East and Africa Synovial Sarcoma Treatment Market Share by Application in 2019
Figure 111. North America Synovial Sarcoma Treatment Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 112. North America Synovial Sarcoma Treatment Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Europe Synovial Sarcoma Treatment Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 114. Europe Synovial Sarcoma Treatment Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Asia Pacific Synovial Sarcoma Treatment Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 116. Asia Pacific Synovial Sarcoma Treatment Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Latin America Synovial Sarcoma Treatment Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 118. Latin America Synovial Sarcoma Treatment Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Middle East and Africa Synovial Sarcoma Treatment Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 120. Middle East and Africa Synovial Sarcoma Treatment Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Porter's Five Forces Analysis
Figure 122. Channels of Distribution
Figure 123. Distributors Profiles
Figure 124. Bottom-up and Top-down Approaches for This Report
Figure 125. Data Triangulation
Figure 126. Key Executives Interviewed
軟部肉腫治療の世界市場（～2026年） Sarcoma are the type of cancer that develops from tissues such as nerves, muscles, fats, blood vessels and deep skin tissues. Increasing cases of soft tissue sarcoma and different types of cancer are expected to boost the growth for soft tissue sarcoma market. Market Analysis and Insights: Global So…- カポジ肉腫（KS）の世界市場（～2026年） Kaposi's sarcoma (KS) is a type of cancer that can form masses in the skin, lymph nodes, or other organs. The skin lesions are usually purplein color. They can occur singularly, in a limited area, or be widespread. It may worsen either gradually or quickly. Lesions may be flat or raised. Four sub-ty…
- 統合失調感情障害治療の世界市場（～2026年） Types of schizoaffective disorders include manic, depressive, mixed, and schizoaffective disorders. The regional market for schizoaffective affective disorders is very common in North America, Europe and Asia Pacific. Market Analysis and Insights: Global Schizoaffective Disorders Treatment Market Th…
- 巨細胞性動脈炎治療の世界市場（～2026年） Giant cell arteritis is also known as temporal arteritis, is a type of disease which causes inflammation of medium and large vessels that occurs only in individuals older than 50 years of age. Seasonal variations in the incidence of giant cell arteritis treatment suggest a possible infective origin …
- 軟骨無形成症治療の世界市場（～2026年） Market Analysis and Insights: Global Achondroplasia Treatment Market The global Achondroplasia Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Achondroplasia Treatment Scope and Market Size Achondroplasia Tre…